What is the ticker symbol for Athira Pharma?

Athira Pharma trades under the ticker ATHA on NASDAQ.

What sector does Athira Pharma operate in?

Athira Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ATHA in a portfolio?

PortView shows ATHA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Athira Pharma (ATHA) Stock Analysis

NASDAQHealthcareBiotechnology

$6.75-6.12%

1-year price historyRange $2.29 – $7.57

52-week range$6.75

$2.20$8.36

What Athira Pharma does

Athira Pharma, Inc., a biopharmaceutical firm in advanced clinical development and based in Bothell, Washington, focuses on creating small molecule treatments designed to revitalize neuronal function and decelerate neurological decline. Its primary therapeutic candidate, ATH-1017, is a unique small molecule that modulates HGF/MET and is capable of crossing the blood-brain barrier. This compound is currently undergoing a Phase 3 clinical trial (LIFT-AD) and a Phase 2 clinical trial (ACT-AD) for Alzheimer's disease. Additionally, ATH-1017 is in Phase 2 clinical trials for Parkinson's disease. The company also has several product candidates in earlier, preclinical stages of development, including ATH-1019 for conditions affecting the peripheral nervous system and ATH-1020 for neuropsychiatric disorders. Founded in 2011, the organization was known as M3 Biotechnology, Inc. until it rebranded to Athira Pharma, Inc. in April 2019.

Key metrics

Market cap

$26.62M

P/E (TTM)

-0.70

EPS (TTM)

$-9.67

Beta

2.80

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$5.48

200-day avg

$4.03

52-week high

$8.36

52-week low

$2.20

CEO

Mark J. Litton

ETFs linked to ATHA

Broad-market and Healthcare sector ETFs an investor holding Athira Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ATHA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ATHA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Athira Pharma?: Athira Pharma trades under the ticker ATHA on NASDAQ.
Which exchange is ATHA listed on?: ATHA is listed on NASDAQ.
What sector does Athira Pharma operate in?: Athira Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ATHA in a portfolio?: PortView shows ATHA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.